Neuro.net Revenue and Competitors
Estimated Revenue & Valuation
- Neuro.net's estimated annual revenue is currently $8M per year.
- Neuro.net's estimated revenue per employee is $130,500
Employee Data
- Neuro.net has 61 Employees.
- Neuro.net grew their employee count by -22% last year.
Neuro.net's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder | Reveal Email/Phone |
Neuro.net Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.9M | 29 | 4% | N/A | N/A |
#2 | $43.4M | 272 | 8% | N/A | N/A |
#3 | $14.1M | 97 | 11% | N/A | N/A |
#4 | $1460M | 8291 | 7% | $1.1B | N/A |
#5 | $310M | 1527 | 20% | N/A | N/A |
#6 | $194.1M | 956 | -5% | N/A | N/A |
#7 | $223.9M | 1080 | -33% | $101.6M | N/A |
#8 | $581.3M | 2708 | 9% | $253.1M | N/A |
#9 | $716.2M | 3528 | 2% | N/A | N/A |
#10 | $801.4M | 3948 | 52% | N/A | N/A |
What Is Neuro.net?
Neuro.net team develops Voice AI that sounds indistinguishable from humans. We have replaced more than 100,000 contact center employees with our virtual agents. They are able to support complex conversations and mimic emotions. In 300 million dialogues, 99% of respondents did not recognize the customer service agent as being an AI driven virtual agents.
keywords:N/A
N/A
Total Funding
61
Number of Employees
$8M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Neuro.net News
MedSurg and Neurotechnology net sales of $2.4 billion increased 10.6% in the quarter and 12.1% in constant currency.
This table compares NeuroOne Medical Technologies and ClearPoint Neuro's net margins, return on equity and return on assets.
Alzamend Neuro, Inc. (NASDAQ:ALZN) Major Shareholder Buys $70,500.00 in Stock. Posted by admin on Apr 25th, 2022.
Other Companies in San Jose
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8M | 61 | 65% | N/A |
#2 | $7.4M | 61 | -8% | $20.5M |
#3 | $8M | 61 | 0% | N/A |
#4 | $8M | 61 | -10% | N/A |
#5 | $8M | 61 | -2% | N/A |